ABIVAX to participate in the European Small-Cap Event in Paris on April 11-12, 2016

Paris, March 31, 2016 – ABIVAX (Euronext Paris : FR0012333284 – ABVX), an emerging leader in developing and commercializing anti-viral drugs and therapeutic vaccines for infectious diseases like HIV/AIDS and chronic hepatitis B (CHB), today announced that it will participate in the European Small-cap Event, to be held on April 11 and 12, 2016, at the Pullman Hotel in Paris.

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41